SPP1 and hepatocellular carcinoma: Thalidomide may act via a series of cascading effects with OPN involving new cell signaling pathways or media to control the expression and molecular behavior of intercellular substances in the hepatocellular carcinoma tumor microenvironment, and thereby directly or indirectly repress the invasion and metastasis of hepatocellular carcinoma.